You Searched For "Novavax" and got 20 results
Sort By:
2 mins read
Record funding for digital health — A tiny biotech gets $1.6 billion for a coronavirus vaccine — The Amazon vet who's leading its COVID-19 testing project
These are the top stories written by Business Insider's healthcare team for July 8.
Lydia Ramsey Pflanzer
2 mins read
Pfizer drops after issuing weaker 2022 outlook, dragging COVID-19 vaccine makers Moderna and Novavax down with it
The drugmaker expects 2022 revenue of $98 billion to $102 billion, which fell below analyst expecta…
Matthew Fox
1 min read
South Korea to roll out Novavax COVID-19 vaccine next week
But officials are expressing cautious hope that the country's high vaccination rate will prevent a…
2 mins read
Novavax surges 23% after scoring COVID-vaccine supply deal with the EU
EU member states may buy up to 200 million doses of Novavax's vaccine through 2023.
Carla Mozée
1 min read
Moderna and Novavax pare losses after Supreme Court strikes down Biden's vaccine mandate for private employers
The vaccine mandate was aimed at private companies with more than 100 employees. The ruling upheld …
Carla Mozée
2 mins read
Novavax climbs 9% after clinical trial shows the firm's COVID-19 vaccine is 90% effective
The company aims to file for FDA approval of NVX-CoV2373 in the third quarter of 2021 and is contin…
Carla Mozée
1 min read
Novavax surges 12% as its COVID-19 vaccine is found to be 96% effective in preventing the original virus strain
The company said its coronavirus vaccine candidate is 96.4% effective against the original virus st…
Shalini Nagarajan
2 mins read
Novavax spikes 76% after UK study shows its COVID-19 vaccine is 89% effective
Shares of Novavax soared more than 2,700% since the company advanced the development of its novel C…
Matthew Fox
2 mins read
Novavax climbs 11% after announcing data from UK vaccine trial are expected in early 2021
The biotech firm initially fell in premarket trading as investors focused on a second delay to its …
Ben Winck
2 mins read
Novavax jumps 10% on deal to provide over 1 billion doses of its COVID-19 vaccine globally
Novavax is working with GAVI to promote equal access to its COVID-19 vaccine globally. The company …
Isabelle Lee
2 mins read
Serum Institute's Covovax gets DCGI approval as a heterologous booster dose
"The Subject Expert Committee of the CDSCO on Wednesday deliberated on the issue and had recommende…
PTI
2 mins read
Novavax soars 13% after inking deal with UK for 60 million doses of coronavirus vaccine
The UK government will collaborate with Novavax on phase 3 trials of its NVX-CoV2373 vaccine, accor…
Ben Winck
1 min read
Novavax skyrockets 21% after saying its COVID-19 vaccine showed promising results in an early trial
Novavax's COVID-19 vaccine, NVX‑CoV2373, "was generally well-tolerated and elicited robust antibody…
Carmen Reinicke
2 mins read
A biotech investor reportedly made $255 million in just 4 weeks on Novavax's 120% surge
Shares of the pharmaceutical company Novavax have surged nearly 2,300% this year. The company is wo…
Carmen Reinicke
1 min read
Novavax leaps 7% after its COVID-19 vaccine won US FDA fast-track authorization
A fast-track would allow Novavax to submit parts of a new drug application, instead of waiting to p…
Shalini Nagarajan
2 mins read
Novavax extends 2-day loss to 31% as the biotech firm delays seeking emergency authorization for its COVID-19 vaccine
"We know that we are delayed from where we thought we would be at this point," Novavax CEO Stanley …
Carla Mozée
2 mins read
Novavax skyrockets 41% after US government grants $1.6 billion for coronavirus vaccine creation
The award is the largest yet from Operation Warp Speed, the Trump administration's plan to develop …
Ben Winck
7 mins read
OPINION: “I would bet on Novovax,” a doctor’s take on how to make the COVID-19 vaccine jabs more effective
So, soon our vaccine basket would be studded with at least four different Covid-19 vaccines. W…
1 min read
Top stories this PM: Novavax 90% effective; UK extends lockdown; Reality Winner is free
The biotech company plans to submit the shot to US regulators by September.
INSIDER
1 min read
COVID-19 vaccine from Novavax begins late-stage trials in the UK — recruits 10,000 people for the study
Maryland-based vaccine maker Novavax said it has begun the late-stage trial of its coronavirus va…